CLINICAL_TRIALS
trial_result
· 2025-03-04
Clinical Trial Update: A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients [Phase 4]
Summary
Phase 4 trial evaluating the impact of clascoterone 1% cream on skin barrier properties in acne-prone patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2025-03-04